About Us
Who We Are?
We are Light AI – a team of visionaries, innovators, and multidisciplinary problem-solvers driven by a shared calling to harness artificial intelligence for the greater good. Guided by compassion and an unwavering commitment to equity, we develop solutions that empower individuals, strengthen communities, and create a brighter future for all — regardless of background or economic circumstances.
Our Journey
Our journey began with a mission to transform diagnostics, addressing global challenges like antimicrobial resistance and healthcare access.
2015: Founding Light AI
Light AI was founded to combat the growing threat of antimicrobial resistance (AMR) caused by the misuse and overprescription of antibiotics. We envisioned solutions that ensure antibiotics were prescribed only when necessary.
2016-2019: Laying the Foundation
Light AI collaborated with leading institutions to create a robust database differentiating viral and bacterial infections. In parallel, the first version of Light AI’s diagnostic device was developed along with validation of algorithms through early trials. Funding was secured to expand its scope.
2020-2021: Pivot to Smartphones
The COVID-19 pandemic presented an opportunity for Light AI to adapt its technology for use with smartphones, enabling fast, non-invasive diagnostics for COVID-19 and other illnesses. This development expanded the potential applications of its technology and demonstrated its versatility in addressing global health concerns.
2022: Cementing Our Footprint
Recognizing the global need for innovative diagnostics, Light AI collaborated with international organizations to validate its strep detection technology in real-world settings, achieving a 96.7% detection accuracy.
2023-2026: Global Readiness
Building on its success, Light AI formed partnerships to enhance its outreach and delivery, particularly in emerging markets such as Africa and India.
Our Purpose
We empower health providers with technology — driven intelligence — assistive innovations to better prevent, diagnose, and manage infectious diseases — transforming care and improving lives.
Our Beliefs
Technology must deliver value
Every solution we create is designed to improve lives and serve the greater good.
Equity drives progress
Breaking down barriers ensures opportunity for all.
Purposeful collaboration amplifies impact
Together, we can achieve the extraordinary.
Compassion fuels purpose
Empathy is at the heart of meaningful change.
Change propels us forward
We evolve to meet the needs of a changing world.
Our Values
Integrity
We uphold the highest ethical standards, fostering trust and transparency in every decision and solution.
Equity
We champion fairness and inclusivity, breaking barriers to ensure access to opportunities for all.
We push boundaries with bold thinking, transforming challenges into impactful solutions.
Innovation
Empowerment
We equip individuals and communities with tools and knowledge to thrive and shape their futures.
We prioritize well-being, creating solutions rooted in empathy and service to the greater good.
Compassion
Impact
We are deliver meaningful results, creating solutions that drive real, lasting change and value.
Our Vision
To be the global leader in advanced intelligence-enabled vision systems to support rapid accurate practitioner diagnosis.
Our People
We continue to expand our impact with a team of multidisciplinary experts – across healthcare, technology – steadfast in our belief that technology should serve humanity.
Leadership Team
Mr. Luna has led organizations across startup, growth-stage, and publicly traded companies, consistently delivering disciplined execution in highly regulated environments while building scalable, revenue-generating platforms.
Peter has founded multiple companies in the fields of Artificial Intelligence and Machine Learning and holds numerous patents in these areas, establishing himself as a pioneer in healthcare AI technology.
A licensed pharmacist and forward-thinking innovator, John has led numerous tech-driven initiatives to enhance operational efficiency and customer care. His contributions have earned him the BC Pharmacy Association’s Lifetime Achievement Award and the Len Marks Pharmacy Advance Award. He continues to serve on multiple boards, driving progress at the intersection of healthcare, retail, and technology.
He was the original founder of the capital pool company that eventually developed into WELL following its qualifying transaction in 2016 with Canada Yoga. Mark has subsequently led the sale of three entities to Well.
Mark was CFO and Executive VP of the Corix Group of Companies which is one of North Americans leading water companies operating in over 30 US states and 3 Canadian Provinces. At Corix he managed a team of 45 accounting and finance professionals and managed a treasury of over $1.6B.
He was CFO and Executive VP of the ALL-SEA Group of Companies, where over a 10-year period, we assisted in developing the company into one of the world’s leading underwater hi-tech maintenances before being sold to USA private Equity Group in 2017.
Over the last few years he has been focused on EV technologies where he has acted as CFO of Taiga Motors (TSX) that he assisted in taking public on the TSX and simultaneous $151m financing as well as the restructuring of ElectaMecanicca (Nasdaq).
Board of Directors
He has led the global launch and commercialization of several key brands, including ELIQUIS, OPDIVO, ORENCIA, HIV, and HCV products.
Robert has created tremendous value at various companies through new product development, sales and marketing, as well as buy-side and sell-side M&A in both private and public environments.
Peter has founded multiple companies in the fields of Artificial Intelligence and Machine Learning and holds numerous patents in these areas, establishing himself as a pioneer in healthcare AI technology.
Advisors
Dr. Talan’s research focuses on acute infections, emergency department-based surveillance, and epidemiological research of emerging infections. He has numerous publications in prestigious journals, and his work has significantly influenced the management of infectious diseases.
Previously, Dr. Bell coordinated malaria diagnostics as a medical and scientific officer at the World Health Organization, was Programme Head of Malaria and Acute Febrile Illness at FIND in Geneva, and Director of Global Health Technologies at Intellectual Ventures Global Good Fund in the USA. He currently consults in biotech and international public health, having authored over 150 publicaitons in global health.
Dr. Dawes also ran a full service primary care practice for 17 years in Oxford. In 2002 he became head of Family Practice at McGill University and set up a primary care centre for McGill in Montreal. In 2010 he became head of Family Practice at the University of British Columbia. He has run observational and interventional experimental studies on hypertension and diabetes as well as other topics in primary care and has over 150 peer reviewed publications.
His current work is focused on precision health and includes prescribing complexity, pharmacogenetics in primary care, and clinical decision support software. From his academic work developing software algorithms for primary care pharmacogenetics he founded and is Medical Director of GenXys Health Care Systems, a University of British Columbia spin out company.
Raymond has published over 250 refereed articles on diverse topics related to data science. He is the Canada Research Chair on data science and analytics, and an elected fellow of the Royal Society of Canada. For both 2022 and 2023, he was named one of the world’s top-75 academic data science leaders by the MIT-based CDO magazine.
Hasnaa holds an M.Sc. in Biomedical Engineering from the University Grenoble Alpes in France and a PhD in Systems Biology from the Goethe University in Frankfurt, Germany. She served as Chair of the TOPRA MedTech committee from January 2021 to May 2023 and as RAPS Western Canada Chapter Leader from January 2023 to December 2024.
Driven by a commitment to advancing the Canadian MedTech ecosystem, she founded Western MedTech in January 2024, an early-stage focused industry group dedicated to advocacy, collaboration, and the adoption of Canadian medical technologies in Canada.
Over the course of his career, Yu and his teams have secured more than 150 U.S. FDA approvals and clearances, spanning PMAs, PMA supplements, IDEs, 510(k)s, and De Novos, for a wide range of devices — from implantable devices to deep learning algorithms.
Diana later joined the University of British Columbia as a Clinical Associate Professor in the Department of Physical Therapy, a position she held until 2020. Alongside her academic career, she co-founded GenXys Health Care Systems and served as Chief Operating Officer, leading multidisciplinary teams of pharmacists, physicians, geneticists, and software engineers in the development of evidence-based clinical decision support software to improve medication prescribing and patient care.
Throughout her academic career, Diana has served as a clinical epidemiology advisor, providing methodological expertise in the design, development, implementation, and evaluation of clinical research across a broad range of healthcare settings.
Message from our Founder
At its heart, Light AI is deeply personal to me. I’ve always believed that innovation should serve humanity, not just as a concept, but as a tool to bridge gaps and solve real problems. That belief is what drives everything we do here.
Growing up, I dreamed of becoming a doctor. I wanted to make an impact by helping others. But as I looked closer, I realized that the problems weren’t just within the walls of hospitals — they were in the systems themselves. So many people lacked access to even basic healthcare. The system wasn’t just strained; for many, it was inaccessible. I knew I wanted to do something to change that.
The challenges are immense. Healthcare specifically has its challenges: overwhelmed by an increasing global population, rising costs, and inefficiencies that leads to poor clinical management, such as antibiotic misuse and antimicrobial resistance. But challenges are also opportunities — opportunities to rethink, reimagine, and rebuild. That’s why I founded Light AI. I saw the potential to combine advanced computational power with something as simple as a smartphone to create tools that make care faster, smarter, and more accessible. Whether it’s empowering healthcare providers to make quicker decisions or delivering life-saving solutions to underserved communities, our mission is to create a tangible, meaningful impact.
Why do I keep doing this? It’s simple — this work fuels me. It’s the only thing I know, the only way I can imagine contributing to the world. Every step forward, every tool we create, every life we touch reminds me why we started this journey. At Light AI, we’re not just innovating for the sake of technology. We’re innovating for the people who need it most. And we’re doing it with the belief that the future of healthcare is not only in what we build but in who we empower.
Thank you for believing in this vision and being part of this mission with us. Together, I know we can make the world healthier, more equitable, and more connected.
Founder & CIO, Light AI Inc.